Fundraising Fox

Eureka Therapeutics

Emeryville, US · Delaware corporation · 2 known investors

Eureka Therapeutics is a clinical-stage biopharmaceutical company developing T-cell-based therapies to treat solid tumors and other cancers. Its pipeline is built on the ARTEMIS and E-ALPHA technology platforms aimed at targeting cancer-specific antigens.

BiotechHealthtech

Founders & leadership

CLCheng Liu
Cheng LiuFounder

Board

SC
Sandy ChauBoard director
HK
Hsing KungBoard director
QF
Qiushi FuBoard director
CC
Chih-Kai ChengBoard director
MC
Michael CannonBoard director

Investors · 2

Acorn Pacific VenturesSan Mateo
YosemitereportedSan Francisco

Reported raises · per SEC filings

Form D private placements

$112.6M disclosed across 4 of 5 rounds · 2014–2023

▶$20MofferedMay 2023 · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Vivien ChanExecutive Officer
  • Cheng LiuExecutive Officer, Director
  • Michael CannonDirector
  • Marvin SamsonDirector
  • William S. Solari IIIDirector
  • "Wai-Yan ""Sandy""" ChauDirector
  • Reed JobsDirector
  • Victor ShumExecutive Officer
  • Jacqueline NorthcutDirector
  • "Chih-Kai ""C.K." ChengDirector
Offering amount
$20M
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$45MraisedJan 2020 · 20 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jacqueline S. NorthcutDirector
  • Marvin T. SamsonDirector
  • William S. Solari IIIDirector
  • Victor ShumExecutive Officer
  • Vivien ChanExecutive Officer
  • Cheng LiuExecutive Officer, Director
  • Michael D. CannonDirector
  • "Wai-Yan ""Sandy""" ChauDirector
  • "Chih-Kai ""C.K.""" ChengDirector
  • Bo FengDirector
Offering amount
$45M
Amount sold
$45M
First sale
Dec 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$20MraisedJun 2018 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Christopher LehmanExecutive Officer
  • Bo FengDirector
  • Lewis T. WilliamsDirector
  • "Chih-Kai ""C.K.""" ChengDirector
  • Michael D. CannonDirector
  • Bijan NejadnikExecutive Officer
  • Wiliam S. Solari IIIDirector
  • Victor ShumExecutive Officer
  • "Wai-Yan ""Sandy""" ChauDirector
  • Cheng LiuExecutive Officer, Director
Offering amount
$20M
Amount sold
$20M
First sale
Jun 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$26.6MraisedMay 2017 · 40 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Sandy ChauDirector
  • Cheng LiuExecutive Officer, Director
  • Hsing KungDirector
  • Qiushi FuDirector
  • Michael CannonDirector
  • Chih-Kai ChengDirector
Offering amount
$60M
Amount sold
$26.6M
Minimum investment
$5K
First sale
Dec 2016
Incorporated
Corporation, California
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$21MraisedSep 2014 · 28 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Hsing KungDirector
  • Qiushi FuDirector
  • Sandy ChauDirector
  • Chih-Kai ChengDirector
  • Cheng LiuExecutive Officer, Director
Offering amount
$21M
Amount sold
$21M
Minimum investment
$10K
First sale
Aug 2014
Incorporated
Corporation, California
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Eureka Therapeutics do?
Eureka Therapeutics is a clinical-stage biopharmaceutical company developing T-cell-based therapies to treat solid tumors and other cancers. Its pipeline is built on the ARTEMIS and E-ALPHA technology platforms aimed at targeting cancer-specific antigens.
Who founded Eureka Therapeutics?
Eureka Therapeutics was founded by Cheng Liu.
Who are Eureka Therapeutics's investors?
Eureka Therapeutics's investors include Acorn Pacific Ventures, Yosemite.
How much funding has Eureka Therapeutics raised?
Eureka Therapeutics has disclosed $112.6M raised across 4 of its 5 known rounds.
Where is Eureka Therapeutics headquartered?
Eureka Therapeutics is headquartered in Emeryville, US.